# FDA 483 - ProCaire, LLC - May 17, 2019

Source: https://www.keypedia.com/records/483/procaire-llc/73cd89da-5e84-4dba-9637-3d0854b79a9b

> FDA 483 for ProCaire, LLC on May 17, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ProCaire, LLC
- Inspection Date: 2019-05-17
- Product Type: drugs
- Office Name: Division of Northeast Imports 
- Summary: ProCaire, LLC, a medical gas manufacturer in Plainville, MA, was cited for significant deficiencies during an FDA inspection. Observations included inadequate contamination controls for oxygen filling equipment, severe data integrity issues with electronic batch records, and a lack of proper calibration for critical equipment. The firm also failed to maintain defined storage areas, establish written QC procedures, and include complete labeling information in batch records, indicating a broad breakdown in quality control and manufacturing practices.

## Related Officers

- [Program Division Director/District Director](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)
- [Regional Manager](https://www.keypedia.com/people/jonah-s-ufferfilge/6bcd2028-9aca-4704-bd7b-c835874fad9d)

Company: https://www.keypedia.com/companies/procaire-llc/652fd352-45cb-4990-b637-391f4843202a

Office: https://www.keypedia.com/offices/division-of-northeast-imports/b20599cf-9797-41fd-947f-6589ef596a94